Biological therapies of inflammatory bowel disease

Transient Cytokine-Induced Liver Injury Following Administration of the Humanized Anti-CD3 Antibody Visilizumab (HuM291) in Crohn's Disease

(2009) Daniel C Baumgart et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases

(2009) Michael Elliott et al.   Annals of the New York Academy of Sciences

Update on genetics in inflammatory disease

(2009) Casper G. Noomen et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Mechanisms of Transendothelial Migration of Leukocytes

(2009) William A. Muller   CIRCULATION RESEARCH

Adult stem cell transplantation in autoimmune disease

(2009) Alan Tyndall et al.   CURRENT OPINION IN HEMATOLOGY

Endothelial signaling in paracellular and transcellular leukocyte transmigration

(2009) Erika et al.   Frontiers in Bioscience-Landmark

Biological Therapies for Inflammatory Bowel Diseases

(2009) Paul Rutgeerts et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

The interleukin-23 axis in intestinal inflammation

(2009) Philip P. Ahern et al.   IMMUNOLOGICAL REVIEWS

Molecular mechanism and function of CD40/CD40L engagement in the immune system

(2009) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis†

(2009) Daniel C. Baumgart et al.   INFLAMMATORY BOWEL DISEASES

Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases

(2009) Valérie Brun et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Sargramostim in patients with Crohn’s disease: results of a phase 1–2 study

(2009) Masakazu Takazoe et al.   JOURNAL OF GASTROENTEROLOGY

Evolving paradigms in the pathogenesis of IBD

(2009) Lloyd Mayer   JOURNAL OF GASTROENTEROLOGY

Adalimumab improves quality of life

(2009) Konstantinos A. Papadakis   Nature Reviews Gastroenterology & Hepatology

Adalimumab for the treatment of Crohn's disease

(2008) Shane M Devlin et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?

(2008) William J. Sandborn   GASTROENTEROLOGY

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

(2008) William J. Sandborn et al.   GASTROENTEROLOGY

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

(2008) James D. Lewis et al.   GASTROENTEROLOGY

Dietary Histidine Ameliorates Murine Colitis by Inhibition of Proinflammatory Cytokine Production From Macrophages

(2008) Ayatoshi Andou et al.   GASTROENTEROLOGY

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

(2008) T Kobayashi et al.   GUT

The Interleukin-23 / Interleukin-17 axis in intestinal inflammation

(2008) Kevin J. Maloy   JOURNAL OF INTERNAL MEDICINE

NF-κB in inflammatory bowel disease

(2008) I. Atreya et al.   JOURNAL OF INTERNAL MEDICINE

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

(2008) Bharat B. Aggarwal et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis

(2007) Satheesh K. Sainathan et al.   INFLAMMATORY BOWEL DISEASES